Market Share of Global Low Molecular Weight Heparin Industry
The low molecular heparin market is moderately competitive due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies holding major market shares. Some key players include Aspen Holdings, Changzhou Qianhong Bio-Pharma, Leopharma A/S, Teva Pharmaceutical Industries Ltd., B. Braun Medical, Inc., Pfizer, Inc., Sanofi, Dr. Reddy's Laboratories Limited, Abbott, and Novartis AG, among others.
Low Molecular Weight Heparin Market Leaders
Aspen Holdings
Changzhou Qianhong Bio-Pharma
B. Braun Medical, Inc.
Pfizer, Inc.
Dr. Reddy's Laboratories Limited
*Disclaimer: Major Players sorted in no particular order